Trial intelligence / Profile preview

Ketorolac versus meperidine for postoperative shivering after laparoscopic cholecystectomy

IRCT20170411033365N6Phase 3Completed

Sponsor
Urmia University of Medical Sciences
Start
Nov 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postanesthetic shivering (PAS) comparing Meperidine with Ketorolac (2 arms). Primary endpoint: Severity of shivering. Started Nov 2024; status: completed.

02

Drugs

ketorolacpethidine
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20170411033365N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170411033365N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call